Novo Nordisk A/S (NVO)
37.32
-0.08
(-0.21%)
USD |
NYSE |
Oct 02, 16:00
37.31
-0.01
(-0.03%)
After-Hours: 20:00
Novo Nordisk Price : 37.32 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 37.64 | 37.65 | 37.17 | 37.32 | 10.26M |
| Oct 01, 2026 | 37.80 | 37.97 | 37.36 | 37.40 | 12.66M |
| Sep 30, 2026 | 38.05 | 38.77 | 37.88 | 37.91 | 21.56M |
| Sep 29, 2026 | 38.21 | 38.38 | 38.05 | 38.31 | 9.404M |
| Sep 28, 2026 | 38.40 | 38.90 | 38.23 | 38.71 | 11.43M |
| Sep 25, 2026 | 38.81 | 38.83 | 38.41 | 38.80 | 10.06M |
| Sep 24, 2026 | 37.95 | 38.72 | 37.92 | 38.62 | 20.06M |
| Sep 23, 2026 | 38.90 | 39.14 | 38.16 | 38.17 | 18.44M |
| Sep 22, 2026 | 39.50 | 39.89 | 39.10 | 39.40 | 24.46M |
| Sep 21, 2026 | 41.05 | 41.17 | 39.54 | 39.80 | 49.34M |
| Sep 18, 2026 | 43.50 | 43.54 | 42.78 | 43.24 | 10.37M |
| Sep 17, 2026 | 41.98 | 43.44 | 41.96 | 43.19 | 12.95M |
| Sep 16, 2026 | 42.47 | 42.72 | 41.47 | 41.71 | 11.67M |
| Sep 15, 2026 | 42.72 | 43.00 | 42.40 | 42.53 | 8.862M |
| Sep 14, 2026 | 43.66 | 43.71 | 43.07 | 43.45 | 6.565M |
| Sep 11, 2026 | 43.20 | 43.50 | 42.72 | 43.07 | 11.03M |
| Sep 10, 2026 | 44.60 | 44.82 | 44.01 | 44.01 | 6.581M |
| Sep 09, 2026 | 45.00 | 45.40 | 44.52 | 44.56 | 8.834M |
| Sep 08, 2026 | 45.58 | 45.91 | 45.14 | 45.16 | 10.35M |
| Sep 04, 2026 | 46.35 | 46.74 | 46.04 | 46.60 | 6.219M |
| Sep 03, 2026 | 47.99 | 48.00 | 46.56 | 47.51 | 8.770M |
| Sep 02, 2026 | 46.05 | 47.00 | 45.91 | 46.77 | 13.60M |
| Sep 01, 2026 | 45.80 | 46.16 | 45.06 | 45.12 | 9.356M |
| Aug 31, 2026 | 45.28 | 45.61 | 44.95 | 45.33 | 7.607M |
| Aug 28, 2026 | 46.17 | 46.21 | 45.40 | 45.61 | 8.505M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AstraZeneca PLC | 156.90 |
| GSK Plc | 47.03 |
| Johnson & Johnson | 256.03 |
| Eli Lilly & Co. | 1142.85 |
| Merck & Co., Inc. | 144.30 |
Price Related Metrics
| PE Ratio | 9.121 |
| PS Ratio | 3.224 |
| PEG Ratio | 0.7238 |
| Price to Book Value | 4.875 |
| Price to Free Cash Flow | 22.07 |
| Earnings Yield | 10.96% |
| Market Cap | 124.87B |
| PEGY Ratio | 0.5238 |
| Operating PE Ratio | 7.106 |
| Normalized PE Ratio | 8.767 |